BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34951042)

  • 1. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
    Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Li Y; Liu J; Wang Y;
    Ann Neurol; 2022 Mar; 91(3):380-388. PubMed ID: 34951042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor versus Clopidogrel in
    Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
    N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor Aspirin vs Clopidogrel Aspirin in
    Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
    Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
    Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
    Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
    Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
    Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
    Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
    Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
    Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].
    Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial.
    Wang D; Gui L; Dong Y; Li H; Li S; Zheng H; Wang A; Meng X; Liu LP; Wang YL; Wang G; Jing J; Li Z; Zhao XQ; Wang YJ
    Stroke Vasc Neurol; 2016 Jun; 1(2):29-36. PubMed ID: 28959461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
    Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
    Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial.
    Suo Y; Pan Y; Chen W; Jing J; Yan H; Li H; Liu L; Zhao X; Wang Y; Meng X; Wang Y;
    Cerebrovasc Dis; 2023; 52(4):442-450. PubMed ID: 36502795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among
    Wang A; Xie X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Meng X; Wang Y
    Ann Intern Med; 2022 Nov; 175(11):1534-1542. PubMed ID: 36315949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
    Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
    N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2.
    Wang C; Jia W; Jing J; Meng X; Wang A; Xu Q; Zhang X; Pan Y; Xie X; Johnston SC; Bath PM; Lin J; Jiang Y; Li H; Wang Y; Zhao X; Liu L; Li Z; Wang Y;
    J Am Heart Assoc; 2023 Nov; 12(21):e031611. PubMed ID: 37889172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.